You are here: Home News Jun 2020 News Jun 2020 Evox Therapeutics announces a multi-target RNA interference and antisense research collaboration and license agreement with Lilly 9th Jun 2020
Evox Therapeutics announces a multi-target RNA interference and antisense research collaboration and license agreement with Lilly 9th Jun 2020